Key filing dates
- Initial claim‑submission deadline: September 30 2025 – investors must file a written notice of loss with Pomerantz LLP (or the court) by this date to preserve the right to participate in the class action.
- Final claim‑submission deadline (if the class is certified): October 15 2025 – after the court’s certification order, any additional claims must be lodged by this later cut‑off to be eligible for any eventual settlement or judgment distribution.
Trading implications
The looming deadlines create a short‑term catalyst for REPL’s stock. As the September 30 deadline approaches, investors with exposure to Replimune will scramble to assess the size of the potential claim pool, which can trigger heightened volatility and volume spikes. If a sizable number of claimants register, the market may price in a larger potential liability, pressuring the share price lower on a “worst‑case” basis. Conversely, a modest claim count could be interpreted as limited exposure, offering a short‑covering opportunity for traders who previously shorted on the liability risk.
From a technical standpoint, REPL has been trading in a tight range around the $4.00‑$4.30 band since the announcement. A break below the $4.00 support line with accompanying high volume could signal a downside move driven by negative sentiment around the class‑action exposure. Conversely, a bounce off the $4.30 resistance—especially if claim filings remain low—might open the door for a short‑term upside, as the market rewards the perception of limited downside.
Actionable insight: Monitor the Sept 30 filing window closely. If claim activity appears muted, consider a short‑term long position near the upper end of the current range, targeting a modest upside to $4.50. If claim filings surge, look for a short opportunity below $4.00 with a stop just above $4.10, as the market may price in a broader liability drag. Keep an eye on any court updates after Oct 15, which could reset the risk profile and prompt a fresh wave of price action.